Only a handful of places left for our September 2026 cohort. Applications close soonApply now →

AlumierMD

Also known as: Alumier MD

AlumierMD is a professional skincare brand offering homecare products and clinic peels. Its range includes cleansers, moisturisers, vitamin-C serums and retinol products, selected through a professional-linked retail model. Suitability and evidence depend on the particular product and the person's skin.

In plain English AlumierMD offers everyday skincare, targeted serums and professional peels. The range includes products for hydration and the appearance of ageing skin, chosen around a person's needs and tolerance. Its IntelliRET retinol product is not intended for pregnancy, breastfeeding or someone planning a pregnancy.

Evidence status

Manufacturer-supported

Named-formula human study; commercial involvement disclosed. A manufacturer-funded, consultant-authored study reported improvements with EverActive C&E + Peptide in 35 women over 56 days, without a comparator. Current product documents establish ingredients and exclusions, while other company outcome summaries provide less methodological detail. Findings belong to the studied formula and population, not automatically to every product or individual ingredient.

What AlumierMD is#

AlumierMD is a professional skincare brand combining homecare and clinic products. Its published history dates launch in Canada and the UK to 2016. The range includes cleansing and moisturising products, targeted serums and professional peels.[3, 5, 6, 7, 8]

The current UK contact is Alumier Labs UK Limited, company 11460521, incorporated in 2018. US terms separately identify Alumier Labs, Inc, at a Canadian address.[1, 2, 3, 12]Brand launch, a local company’s incorporation and the identity of a sales/contact entity are distinct facts.

This reference describes the brand’s particular products and evidence. The vitamin C, retinoids and peptides entries explain the wider ingredient science.

Use of AlumierMD in aesthetic practice#

Its professional model links product choice to an assessment of the person’s concern and existing routine. Current product FAQs also describe online purchase through a selected partner clinic.[1, 5, 7][3, 5, 6, 7, 8] This is a practical distribution model; a consultation can address tolerance, product overlap and whether the concern needs medical review.

Representative parts of the range include:

  • HydraDew: a rich moisturiser intended for dry skin and hydration.[7]
  • EverActive C&E + Peptide: a serum with vitamin C held separately in a dry component before preparation, with vitamin E and a peptide in the formulation.[4, 5]i
  • IntelliRET 0.3+:a retinol product with additional conditioning ingredients and the company’s encapsulation approach.[6]
  • Professional peels: IntelliRET Boost, Radiant TXA, Radiant30, Radiant20/10, Detox Clear and Vitamin A Boost are distinct named products or services.[8]

For supply, Great Britain and Northern Ireland have separate cosmetic frameworks. Relevant obligations include a responsible person, product-safety documentation, notification and support for product claims. NI guidance describes the applicable EU/Windsor arrangements; GB guidance applies to England, Scotland and Wales.[3, 10, 11]iProfessional practice must also stay within the individual’s training, competence and applicable requirements.

Contraindications and cautions#

Pregnancy, breastfeeding or planning pregnancy:the current IntelliRET label excludes all three. The company’s peel information also advises deferring its peels during pregnancy or breastfeeding.[6][8] These are specific manufacturer cautions, not a statement that every item in the brand has the same exclusion.

Current irritation and previous reactions: assess the exact product and the existing routine before introducing a retinol or peel. The retrieved labels include irritation/discomfort warnings and product-specific eye or mucosal precautions.[4, 5, 6, 7, 9]i The formula, its vehicle and other exposures matter alongside the headline ingredient.

Professional peel suitability requires the current instructions for the particular peel. The shared AlumierMD name does not make the retinol/lactic-acid IntelliRET Boost interchangeable with another member of the peel range.[8]

Clinical uses and the evidence behind them#

Facial photoageing: EverActive C&E + Peptide

Lintner, Gerstein and Solish studied the named serum in 35 Caucasian women aged 49–74, mean age 64, with actual Fitzpatrick II/III skin types. The study assessed the face over 56 days. It was funded by ALUMIER MD Laboratories, and all three authors were consultants for Alumier Labs.[4]

The studied formulation combined 15% w/v L-ascorbic acid, tocopheryl acetate and 5 ppm palmitoyl tripeptide-38. Instrumental assessments reported improvements in periorbital surface roughness and facial colour measurements; participants also reported favourable changes in their skin’s appearance. The authors concluded positively about the combined serum.[4, 5]i

This was an open-label before/after study without a comparator. It therefore provides a measured human observation in that population, with uncertainty about how much change was due to the formula rather than other influences. Current product information lists the same principal components and cites this study, but full historical-to-current formula equivalence was not independently established here.[4][4, 5]i

Hydration and topical appearance care

HydraDew is positioned for dry skin and hydration and includes glycerin, emollients, niacinamide, sodium hyaluronate and peptides. IntelliRET 0.3+ combines retinol with niacinamide, hyaluronate and peptides for appearance-focused care.[7][6] These are useful descriptions of the current formulas and intended uses; they should be distinguished from the named human study above.

Professional resurfacing services

The peel portfolio provides different formulation options for professional appearance care, including the retinol/lactic-acid combination described for IntelliRET Boost.[8] Selection belongs to the assessed concern and the current product instructions. The chemical-peel guide explains procedure education; a brand menu alone does not determine the best procedure for a medical condition.

Selecting an AlumierMD product or treatment#

Identify a specific aim—such as a more comfortable moisturising routine or improvement in the appearance of photoaged skin—and match it to a particular formula. Consider the current routine, prior reactions, pregnancy status where relevant, and whether a professional procedure is actually indicated.[5, 6, 7, 8, 9]

For the vitamin-C serum, match the current formula to the named preparation evaluated in the study. For retinol and peels, follow the particular label and professional instructions rather than constructing a regimen from concentration numbers alone.[4, 5, 6, 7, 8]

The retail route is professional-linked, including online ordering. Because current product FAQs and general terms differ on whether a physical consultation is mandatory, check the current purchasing arrangements rather than promising a universal in-person requirement.[1, 5, 7]

Adverse effects and their management#

Stinging, redness, dryness or an eczematous eruption can signal product intolerance. The retrieved AlumierMD labels advise stopping use for excessive discomfort or irritation and seeking professional advice.[4, 5, 6, 7, 9]i Cosmetic dermatitis can be irritant or allergic; identifying the responsible exposure may require clinical assessment.[9]

The small EverActive cohort reported no adverse effects attributed to the serum during its 56-day observation. That is reassuring for those observed participants, not a guarantee for all ages, skin types or concurrent routines.[4]

Persistent, recurrent or severe dermatitis symptoms warrant GP assessment. Record the exact product, timing and other recent exposures so the reaction can be assessed and reported appropriately.[4, 5, 6, 7, 9]i

Referral and scope boundaries#

A skincare professional can help document the routine, recognise a possible product reaction and direct someone towards appropriate care. Persistent or severe dermatitis needs medical assessment rather than successive substitutions of active products.[4, 5, 6, 7, 9]i

Brand choice follows assessment; it does not establish a diagnosis. Acne vulgaris, rosacea and hyperpigmentation provide the relevant clinical and referral distinctions. Product training and commercial access do not replace the professional’s responsibilities for the actual service.

Mechanism of action#

The range contains several kinds of intervention, so there is no single AlumierMD mechanism. HydraDew combines water-attracting and conditioning ingredients; IntelliRET supplies retinol alongside other ingredients, with encapsulation described by the company.[7][6]

The EverActive paper proposes complementary antioxidant and matrix-supporting roles for its vitamin-C, vitamin-E and peptide combination. Its human measurements concern skin-surface appearance, colour and participant perception—not skin-biopsy measurement of collagen synthesis.[4] The ingredient entries explain the wider mechanisms; the clinical observation belongs to the complete studied formula.

Commonly misstated claims#

Combined-formula and individual-ingredient effects

Claim heard:“The EverActive trial proves that its vitamin C alone produced the result.”

Literature finding: The study tested vitamin C, vitamin E and a peptide together, without separate ingredient arms or a comparator.[4]

Supported statement: It reports outcomes with a named combination serum; the contribution of each component was not isolated.

Maximum results and expected benefit

Claim heard:“An ‘up to’ result tells us the average improvement a client can expect.”

Literature finding:IntelliRET’s company page gives headline multipliers alongside an internal 24-person study description and results from 22 people over 28 days. It does not supply a complete comparator/methods report allowing those headlines to be interpreted as mean comparative effects.[6]i

Supported statement: A maximum or promotional multiplier is not a client-level forecast or an established average treatment advantage.

Professional positioning and product classification

Claim heard:“Medical-grade skincare is a separate medicinal approval.”

Literature finding: The brand uses professional/medical-grade positioning; the official GB and NI documents describe the applicable cosmetic duties and product-claim responsibilities.[3, 10, 11]i

Supported statement: Assess legal classification and evidence for the specific product; the marketing description alone establishes neither medicinal authorisation nor superiority.

Areas of remaining uncertainty#

  • How well do the serum findings generalise? Broader populations and comparative studies would help a practitioner judge likely benefit beyond the women in the 56-day study.[4]
  • Which change is meaningful to the client? Instrumental appearance measures and self-perception are complementary; agree the goal before choosing a targeted product.[4]
  • How should homecare fit around a proposed peel? The individual skin assessment and current product-specific instructions determine that plan; the range does not imply a universal combination schedule.[5, 6, 7, 8]

Frequently asked questions#

Does the brand include ordinary moisturisers as well as actives?

Yes. HydraDew is an example of a moisturiser intended for dry skin and hydration, alongside targeted products such as EverActive and IntelliRET.[3, 5, 6, 7, 8]

Why are the brand’s vitamin-C crystals kept separately?

The company presents the separate dry component as part of the product’s fresh-preparation design. Follow its storage and preparation information for that product.[4, 5]i

What should be reviewed before booking a peel?

The concern being treated, current skin condition, pregnancy or breastfeeding status, existing products and the exact peel proposed. The manufacturer’s current instructions govern the named product.[8]

References#

Each source is graded by evidence tier. Tier 4 material (manufacturer documents, expert consensus, practitioner experience) is useful for protocol and context, and is never presented as equivalent to independent clinical evidence.

  1. AlumierMD UK. Contact, terms and privacy information. Accessed 16 September 2026.Tier 4Supports: Alumier Labs UK Ltd, company 11460521, and professional-linked retail terms.Funding / interest: Commercial company terms; identity/distribution evidence, not clinical research.
  2. Companies House. Alumier Labs UK Limited, company 11460521. Accessed 16 September 2026.Tier 1Supports: Active UK company incorporated 11 July 2018; local corporate identity, not ultimate brand ownership.Funding / interest: Public corporate register.
  3. AlumierMD UK. Our story. Accessed 16 September 2026.Tier 4Supports: Company account of 2016 launch in Canada/UK and professional partner model; brand history differs from local incorporation date.Funding / interest: Manufacturer history and positioning.
  4. Lintner K, Gerstein F, Solish N. A serum containing vitamins C & E and a matrix-repair tripeptide reduces facial signs of aging as evidenced by Primos analysis and frequently repeated auto-perception. J Cosmet Dermatol. 2020;19(12):3262–3269. doi:10.1111/jocd.13770. PMID:33103342.Tier 3Supports: Uncontrolled 56-day facial study of named EverActive C&E + Peptide serum in 35 Caucasian women aged 49–74, actual phototypes II/III; improved surface-roughness/colour and self-perception outcomes, not isolated-ingredient or biopsy evidence.Funding / interest: Funded by ALUMIER MD Laboratories. All three authors were consultants for Alumier Labs.
  5. AlumierMD UK. EverActive C&E + Peptide. Current product information accessed 16 September 2026.Tier 4Supports: Current formula description, separate dry vitamin-C component, referenced 2020 study, irritation/eye-contact cautions and online clinic-linked retail FAQ.Funding / interest: Manufacturer/distributor technical product information.
  6. AlumierMD UK. IntelliRET 0.3+. Current product information accessed 16 September 2026.Tier 4Supports: 0.3% retinol, additional ingredients, manufacturer encapsulation description, pregnancy/lactation/planning-pregnancy exclusion and limited internal outcome summary.Funding / interest: Manufacturer product page and internal study summary; no independent trial methods supplied.
  7. AlumierMD UK. HydraDew. Current product information accessed 16 September 2026.Tier 4Supports: Rich moisturiser's intended dry-skin/hydration use, glycerin/emollients/niacinamide/hyaluronate/peptides, irritation caution and professional-linked retail.Funding / interest: Manufacturer technical label and product description.
  8. AlumierMD UK. Chemical peels. Current professional portfolio and FAQs accessed 16 September 2026.Tier 4Supports: Named peel portfolio, IntelliRET Boost retinol/lactic-acid description and company's pregnancy/breastfeeding deferral advice.Funding / interest: Manufacturer service/product descriptions; not independent head-to-head evidence.
  9. NHS. Contact dermatitis. Reviewed 3 May 2023; accessed 16 September 2026.Tier 4Supports: Irritant/allergic dermatitis from cosmetics and GP review for persistent, recurrent or severe symptoms.Funding / interest: NHS public guidance; no commercial sponsor stated.
  10. OPSS. Regulation 2009/1223 and Cosmetic Products Enforcement Regulations2013: Great Britain. Accessed 16 September 2026.Tier 1Supports: GB cosmetic safety, responsible-person, information-file, notification and claims responsibilities.Funding / interest: Official government regulatory guidance.
  11. OPSS. Regulation 2009/1223 and Cosmetic Products Enforcement Regulations2013: Northern Ireland. Accessed 16 September 2026.Tier 1Supports: Distinct NI/EU cosmetics framework under Windsor arrangements; notification and claims responsibilities are not therapeutic approval.Funding / interest: Official government regulatory guidance.
  12. AlumierMD US. Contact, terms and privacy information. Identity passages accessed 16 September 2026.Tier 4Supports: Notices identify Alumier Labs, Inc in Canada; privacy identifies Alumier Group Holdings Limited and Alumier entities. Does not establish an audited ownership chain.Funding / interest: Commercial corporate terms/privacy publication.